ImmuneWorks Alternatives & Competitors

12 companies similar to ImmuneWorks — Pioneering safe and effective treatments for autoimmune lung diseases through gr...

AnTolRx

Innovative therapies for autoimmune diseases through targeted immune-regulation using prop...

Series A $4.00M

Biotechnology Health Care

Lung Therapeutics

Pioneering safer pathways in lung disease treatment with pharmaceutical solutions.

11-50 Series C $53.91M

Biotechnology Health Care +1

Kanyos Bio

1 Venture round $26.80M

Cambridge, United States

Biotechnology Health Care +1

Apitope

Develops drugs for treatments of allergic diseases

1 Series B $22.00M

Diepenbeek, Belgium

Biotechnology Health Care

Track all ImmuneWorks competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

DBV Technologies

On a mission to advance epicutaneous immunotherapy using our innovative technology platfor...

187 Post-IPO Equity $239.80M

Chatillon, France

Biopharma Biotechnology +1

Adendra Therapeutics

Translating dendritic cell biology into new therapies for cancer and autoimmunity.

3 Series A $53.00M

London, United Kingdom

Biopharma Biotechnology +1

Telormedix

Pioneering targeted immunity for cancer and autoimmune disease treatment through innovativ...

Series B $31.16M

Biopharma Biotechnology +2

Alumis

Transforming the lives of patients living with immune-mediated diseases using a precision...

249 Series C $529.00M

South San Francisco, Unit...

Biotechnology Health Care +1

NeRRe Therapeutics Ltd

Developing a breakthrough treatment for the disabling chronic cough associated with idiopa...

9 Series B $61.40M

Stevenage, United Kingdom

Biotechnology Health Care

FimmCyte

First disease modifying treatment for Endometriosis.

7 Seed $1.30M

Basel, Switzerland

Biotechnology Health Care

Inversago Pharma

Pioneering innovative therapies to enhance the lives of patients with metabolic and fibrot...

Series C $137.00M

Biopharma Biotechnology +2

Vastera

Pioneering innovative treatments for cardiovascular and cancer diseases through novel redo...

Series B $23.50B

Biotechnology Health Care +1

About ImmuneWorks

ImmuneWorks, Pioneering safe and effective treatments for autoimmune lung diseases through groundbreaking discoveries. Founded in 2006 in Indianapolis, Indiana, ImmuneWorks focuses on developing immune tolerance therapies for patients suffering from severe autoimmune lung diseases. The company's innovative approach ste...

Business keywords

ImmuneWorks, Autoimmune Lung Diseases, Immune Tolerance Therapies, Idiopathic Pulmonary Fibrosis, Antigen-Specific Autoimmunity, Treatment Development, Groundbreaking Discoveries, Scientific Research, Healthcare Innovation, Biomedical Science, Pulmonary Disease Therapies, Medical Research, Immunotherapy, Startup

Frequently Asked Questions

Companies similar to ImmuneWorks include AnTolRx, Lung Therapeutics, Kanyos Bio, Apitope, DBV Technologies. They work in Biotechnology and Health Care and share ImmuneWorks's focus on healthcare innovation, immunotherapy and medical research.

Bounce Watch lists 12 companies that share ImmuneWorks's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches ImmuneWorks and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

ImmuneWorks Profile AnTolRx Alternatives Lung Therapeutics Alternatives Kanyos Bio Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at ImmuneWorks on 13 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.